Evaluation of gabapentin treatment in neuropathic pain;Utilité de la gabapentine dans les douleurs neurogènes

Medecine et Hygiene

Volumn 61, Issue 2443, 2003, Pages 1352-1357

  Girardin, François ^a   Desmeules, Jules Alexandre ^a   Piguet, Valérie ^a   Dayer, Pierre ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; GABAPENTIN;

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFUSION; DIABETIC NEUROPATHY; DISEASE COURSE; DRUG BINDING; DRUG EFFICACY; DRUG METABOLISM; DRUG SCREENING; DRUG TOLERABILITY; FUNCTIONAL DISEASE; GABAERGIC TRANSMISSION; HUMAN; KIDNEY FUNCTION; LIVER CLEARANCE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PRESCRIPTION; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; SYMPTOM; URINARY EXCRETION; VERTIGO;

EID: 0038824927     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Mendell JR. Clinical practice. Painful sensory neuropathy, N Engl J Med. 2003; 348: 1243-55.
2. Rosner H, et al. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996; 12: 56-8.
3. Perez CM, et al. Treatment of ciguatera poisoning with gabapentin. N Engl J Med, 2001; 344: 692-3.
4. Chapman V, et al. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 1998; 75: 261-72.
5. Gee NS, et at, The novel anticonvulsant drug, gabapentin, binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996; 8: 5768-76.
6. Suman-Chauhan N, et al. Characterisation of [3H]gabapentin binding to a novel site in rat brain: Homogenate binding studies. Eur J Pharmacol 1993; 15: 293-301.
7. Berry DJ. The absorption of gabapentin following high dose escalation. Seizure 2003; 12: 28-36.
8. Micromedex CD-ROM, Drug information System. Edition 2003.
9. Backonja M, et el. Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003; 25: 81-104.
10. Backonja M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998; 280: 1831-6.
11. Rowbotham M, et al. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998; 280: 1837-42.
12. Rice AS, et al. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001; 92: 215-24.
13. Morello CM, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999; 159: 1931-7.
14. McQuay H, et al. Anticonvulsant drugs for management of pain: A systematic review. BMJ 1995; 311: 1047-52.
15. Serpell MG. Gabapentin in neuropathic pain syndromes: A randomised, double-blind, placebo-controlled trial. Pain 2002; 99: 557-66.
16. Sigler RE. Pancreatic acinar cell neoplasia in male Wistar rats following 2 years of gabapentin exposure. Toxicology 1995; 12: 73-82.